U.S.
Alabama
Arizona
California
Colorado
Florida
Illinois
Kentucky
Louisiana
Massachusetts
Maryland
Michigan
Minnesota
Mississippi
North Carolina
New York
Ohio
Tennessee
Texas
Utah
Virginia
Washington
Evaluating the investigational drug, CVC for individuals with NASH with Liver Fibrosis
This research study is now enrolling
CENTAUR, an International Study Evaluating the Effectiveness and Safety of Cenicriviroc (CVC) vs Placebo for Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Source: The National Institute of Diabetes and Digestive and Kidney Diseases
Adults who are overweight or have type 2 diabetes may be eligible to participate in this study. If you are a physician or if you or someone you know has NASH and liver fibrosis and wish to learn more about the CENTAUR study, please visit:
http://www.clinicaltrials.gov/ct2/show/NCT02217475
or contact: clinical@tobiratherapeutics.com
For complete information on the CENTAUR Study, please visit http://www.clinicaltrials.gov/ct2/show/NCT02217475
CENTAUR is currently enrolling subjects in the following countries.
Please visit http://www.clinicaltrials.gov/ct2/show/NCT02217475
or contact: clinical@tobiratherapeutics.com for more information
Alabama
Arizona
California
Colorado
Florida
Illinois
Kentucky
Louisiana
Massachusetts
Maryland
Michigan
Minnesota
Mississippi
North Carolina
New York
Ohio
Tennessee
Texas
Utah
Virginia
Washington
Belgium
France
Germany
Spain
UK
Poland
Moldova
Australia
Hong Kong
701 Gateway Blvd, Suite 300, South San Francisco, CA 94080
+1 (650) 741-6625
info@tobiratherapeutics.com
Disclaimer: This site contains information that was believed current as of the date of inclusion in the site. While we may periodically update or correct information in this site, we make no representation or warranty as to its accuracy, and we do not intend to update such information.
This site contains links to other websites maintained by other companies. We provide these links to you only as a convenience. The inclusion of any link does not imply endorsement by us of any third party site. We do not have any control over the content of such third party sites and assume no responsibility whatsoever for the accuracy on any information contained on such third party sites. We may revise this Notice at any time by updating this posting. You are bound by any such revisions and should therefore visit this Legal Notice section each time you access this site to review the then-current conditions applicable to your use at that time.
© Tobira, 2015. All Rights Reserved. Website design by Hane Chow, Inc.